ScienceDex / Researcher record
Andrew James Aguirre
- Dana-Farber Cancer Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,518,856 | 2 | #8,416 |
| 2025 | $2,070,914 | 3 | #6,322 |
| 2026 | $2,052,164 | 3 | #10,167 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20242 records
- FY20253 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10995625Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-0701-6203Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Andrew James Aguirre as a PI. Multi-PI records show the full award amount for context.
- 5U01CA274276-05U01Co-investigatorStromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity$1Maward amount
- 5R01CA276268-04R01Contact PIMechanisms of response and resistance to KRAS inhibition in pancreatic cancer$561.8Kaward amount
- 5R01CA233626-07R01Co-investigatorThe function of the PRMT5 methylosome in MTAP deleted cancers$453.4Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Andrew James Aguirre as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8416
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Andrew James Aguirre.